Contract research organization ICON is set to acquire rival PRA Health Sciences in a $12 billion deal that will vault the combined company into second place among clinical trial services providers.

NEW YORK--KKR, a leading global investment firm, today announced the signing of a definitive agreement to acquire ReSearch Pharmaceutical Services Inc. ("RPS"), a leading global contract research ...

ICON has agreed to acquire PRA Health Sciences for approximately $12 billion in cash and stock, the companies said, in a deal that continues the consolidation of contract research organizations (CROs) ...

Contract research company PRA Health Sciences has established a new Rare Disease Advisory Committee (RDAC) designed to help integrate the needs of patients into rare disease studies. PRA says this ...

Raleigh-based PRA Health Sciences, one of the largest contract research companies in the world, has been bought for $12 billion. PRA said Wednesday it is entering into an agreement to be acquired by ...

ICON Public is a global clinical research organization that provides services for the pharmaceutical, biotechnology, and medical device industries. The clinical research organization sector is ...

RALEIGH – PRA Health Sciences is working to help clinical trials go virtual. That’s because it has designed a new mobile clinical trial platform, CHIEF-HF (Canagliflozin: Impact on Health Status, ...

Dr. Isaac Rodriguez-Chavez brings vast expertise in regulatory compliance and clinical research methodology to PRA’s industry-leading DCT practice “We are honored to have one of the pioneers in ...